Secukinumab May Significantly Reduce Inflammation in Patients With Hidradenitis Suppurativa

Secukinumab affects levels of inflammatory biomarkers, and monitoring levels can help investigators understand how patients are responding to treatment.

Related Keywords

San Diego ,California ,United States ,American ,Secukinumab Cosentyx ,American Academy Of Dermatology ,Novartis ,American Academy ,Annual Meeting ,